ReP USP - Resultado da busca

Artigo de periodico
Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model (2022)
Pereira, Maurício dos Santos ; Nascimento, Glauce Crivelaro do ; Bortolanza, Mariza ; Michel, Patrick Pierre; Raisman-Vozari, Rita; Del Bel, Elaine Aparecida
Fonte: Frontiers in Pharmacology. Unidades: FMRP, FORP
Assuntos: NEUROLOGIA, INFLAMAÇÃO, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Maurício dos Santos et al. Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model. Frontiers in Pharmacology, v. 13, 2022Tradução . . Disponível em: https://doi.org/10.3389/fphar.2022.1045465. Acesso em: 08 out. 2025.
APA
Pereira, M. dos S., Nascimento, G. C. do, Bortolanza, M., Michel, P. P., Raisman-Vozari, R., & Del Bel, E. A. (2022). Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model. Frontiers in Pharmacology, 13. doi:10.3389/fphar.2022.1045465
NLM
Pereira M dos S, Nascimento GC do, Bortolanza M, Michel PP, Raisman-Vozari R, Del Bel EA. Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model [Internet]. Frontiers in Pharmacology. 2022 ; 13[citado 2025 out. 08 ] Available from: https://doi.org/10.3389/fphar.2022.1045465
Vancouver
Pereira M dos S, Nascimento GC do, Bortolanza M, Michel PP, Raisman-Vozari R, Del Bel EA. Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model [Internet]. Frontiers in Pharmacology. 2022 ; 13[citado 2025 out. 08 ] Available from: https://doi.org/10.3389/fphar.2022.1045465
Artigo de periodico
Doxycycline and its derivative, COL‐3, decrease dyskinesia induced by L-DOPA in hemiparkinsonian rats (2021)
Bortolanza, Mariza ; Nascimento, Glauce Crivelaro do ; Raisman‐Vozari, Rita; Del Bel, Elaine Aparecida
Fonte: British Journal of Pharmacology. Unidades: FMRP, FORP
Assuntos: FÁRMACOS (SISTEMA NERVOSO CENTRAL), DOENÇA DE PARKINSON, ASTRÓCITOS, INFLAMAÇÃO, ESPÉCIES REATIVAS DE OXIGÊNIO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORTOLANZA, Mariza et al. Doxycycline and its derivative, COL‐3, decrease dyskinesia induced by L-DOPA in hemiparkinsonian rats. British Journal of Pharmacology, v. 178, n. 13, p. 2595-2616, 2021Tradução . . Disponível em: https://doi.org/10.1111/bph.15439. Acesso em: 08 out. 2025.
APA
Bortolanza, M., Nascimento, G. C. do, Raisman‐Vozari, R., & Del Bel, E. A. (2021). Doxycycline and its derivative, COL‐3, decrease dyskinesia induced by L-DOPA in hemiparkinsonian rats. British Journal of Pharmacology, 178( 13), 2595-2616. doi:10.1111/bph.15439
NLM
Bortolanza M, Nascimento GC do, Raisman‐Vozari R, Del Bel EA. Doxycycline and its derivative, COL‐3, decrease dyskinesia induced by L-DOPA in hemiparkinsonian rats [Internet]. British Journal of Pharmacology. 2021 ; 178( 13): 2595-2616.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/bph.15439
Vancouver
Bortolanza M, Nascimento GC do, Raisman‐Vozari R, Del Bel EA. Doxycycline and its derivative, COL‐3, decrease dyskinesia induced by L-DOPA in hemiparkinsonian rats [Internet]. British Journal of Pharmacology. 2021 ; 178( 13): 2595-2616.[citado 2025 out. 08 ] Available from: https://doi.org/10.1111/bph.15439
Artigo de periodico
Contributive role of TNF-α to L-DOPA-induced dyskinesia in a unilateral 6-OHDA lesion model of parkinson’s disease (2021)
Pereira, Maurício dos Santos ; Abreu, Gabriel Henrique Dias; Rocca, Jeremy; Hamadat, Sabah; Raisman-Vozari, Rita; Michel, Patrick Pierre; Del Bel, Elaine Aparecida
Fonte: Frontiers in Pharmacology. Unidade: FORP
Assuntos: ASTROCITOMA, CANABINOIDES, GLUTAMATOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Maurício dos Santos et al. Contributive role of TNF-α to L-DOPA-induced dyskinesia in a unilateral 6-OHDA lesion model of parkinson’s disease. Frontiers in Pharmacology, v. 11, p. 1-16, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2020.617085. Acesso em: 08 out. 2025.
APA
Pereira, M. dos S., Abreu, G. H. D., Rocca, J., Hamadat, S., Raisman-Vozari, R., Michel, P. P., & Del Bel, E. A. (2021). Contributive role of TNF-α to L-DOPA-induced dyskinesia in a unilateral 6-OHDA lesion model of parkinson’s disease. Frontiers in Pharmacology, 11, 1-16. doi:10.3389/fphar.2020.617085
NLM
Pereira M dos S, Abreu GHD, Rocca J, Hamadat S, Raisman-Vozari R, Michel PP, Del Bel EA. Contributive role of TNF-α to L-DOPA-induced dyskinesia in a unilateral 6-OHDA lesion model of parkinson’s disease [Internet]. Frontiers in Pharmacology. 2021 ; 11 1-16.[citado 2025 out. 08 ] Available from: https://doi.org/10.3389/fphar.2020.617085
Vancouver
Pereira M dos S, Abreu GHD, Rocca J, Hamadat S, Raisman-Vozari R, Michel PP, Del Bel EA. Contributive role of TNF-α to L-DOPA-induced dyskinesia in a unilateral 6-OHDA lesion model of parkinson’s disease [Internet]. Frontiers in Pharmacology. 2021 ; 11 1-16.[citado 2025 out. 08 ] Available from: https://doi.org/10.3389/fphar.2020.617085

Unidades USP

ReP

Filtros

Autores

Assuntos

Agência de fomento

Indexado em